Inhibition of endothelial cell functions by novel potential cancer chemopreventive agents

Biochemical and Biophysical Research Communications

Volumn 325, Issue 1, 2004, Pages 287-295

  Bertl, Elisabeth ^a   Becker, Hans ^b   Eicher, Theophil ^b   Herhaus, Christian ^a   Kapadia, Govind ^c   Bartsch, Helmut ^a   Gerhäuser, Clarissa ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c HOWARD UNIVERSITY   (United States)

Author keywords

Anti angiogenic; Anti endothelial; Bibenzyls; Cancer chemoprevention; Chalcones; HCT 116; Human microvascular endothelial cells; Migration; NIH 3T3; Polyphenols; Proliferation; SK BR3; Tube formation

Indexed keywords

1,2,5,7 TETRAHYDROXYANTHRAQUINONE; 2,2',4' TRIMETHOXYCHALCONE; 3' BROMO 2,4 DIMETHOXYCHALCONE; ANTINEOPLASTIC AGENT; BIBENZYL DERIVATIVE; CARNOSIC ACID; ISOXANTHOHUMOL; LUNULARIC ACID; MONOACYLPHLOROGLUCINOL ISOASPIDINOL B; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER PREVENTION; CELL DIFFERENTIATION; CELL FUNCTION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS INHIBITION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

BRYOPHYTA;

EID: 7444223476     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.10.032     Document Type: Article

References (42)

1. E. Bertl, K. Klimo, E. Heiss, F. Klenke, P. Peschke, H. Becker, T. Eicher, C. Herhaus, G. Kapadia, H. Bartsch, and C. Gerhauser Identification of novel inhibitors of angiogenesis using a human in vitro anti-angiogenic assay Int. J. Cancer Prev. 1 2004 47 61
2. P. Carmeliet Manipulating angiogenesis in medicine J. Intern. Med. 255 2004 538 561
3. C. Gerhauser, K. Klimo, E. Heiss, I. Neumann, A. Gamal-Eldeen, J. Knauft, G.Y. Liu, S. Sitthimonchai, and N. Frank Mechanism-based in vitro screening of potential cancer chemopreventive agents Mutat. Res. 523-524 2003 163 172
4. P. Karrer Über Oxycarbonylverbindungen II. Synthetische Versuche in der Filixgruppe Helv. Chim. Acta 2 1991 466 481
5. C. Gerhauser, A.P. Alt, K. Klimo, J. Knauft, N. Frank, and H. Becker Isolation and potential cancer chemopreventive activities of phenolic compounds of beer Phytochem. Rev. 1 2002 369 377
6. C.H. Brieskorn, and H. Domling Carnosolsäure, der wichtigste antioxidative Inhaltsstoff des Rosmarin- und Salbeiblattes Z. Lebensm. Unters. For. 141 1969 10 16
7. C. Gerhauser, A. Alt, E. Heiss, A. Gamal-Eldeen, K. Klimo, J. Knauft, I. Neumann, H.-R. Scherf, N. Frank, H. Bartsch, and H. Becker Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop Mol. Cancer Ther. 1 2002 959 969
8. C. Herhaus, C. Gerhauser, and K. Klimo Modulation of drug-metabolizing enzymes by non-polar chalcones-a combinatorial approach J. Cancer Res. Clin. Oncol. 125 Suppl. 1999 S38
9. F. Orsini, and L. Verotta Stilbenes and bibenzyls with potential anticancer or chemopreventive activity Y. Zappia Advances in Nutrition and Cancer 2 1999 Kluwer Academic/Plenum Publishers New York 169 186
10. E. Brakenhielm, R. Cao, and Y. Cao Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes FASEB J. 15 2001 1798 1800
11. A.E. Gururaj, M. Belakavadi, D.A. Venkatesh, D. Marme, and B.P. Salimath Molecular mechanisms of anti-angiogenic effect of curcumin Biochem. Biophys. Res. Commun. 297 2002 934 942
12. Y.D. Jung, and L.M. Ellis Inhibition of tumor invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea Int. J. Exp. Pathol. 82 2001 309 316
13. Y. Cao, and R. Cao Angiogenesis inhibited by drinking tea Nature 398 1999 381
14. S. Garbisa, S. Biggin, N. Cavallarin, L. Sartor, R. Benelli, and A. Albini Tumor invasion: molecular shears blunted by green tea Nat. Med. 5 1999 1216
15. A. Jekunen, and K. Kairemo Inhibition of angiogenesis at endothelial cell level Microsc. Res. Tech. 60 2003 85 97
16. R. Longo, R. Sarmiento, M. Fanelli, B. Capaccetti, D. Gattuso, and G. Gasparini Anti-angiogenic therapy: rationale, challenges and clinical studies Angiogenesis 5 2002 237 256
17. F. Tosetti, N. Ferrari, S. De Flora, and A. Albini Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents FASEB J. 16 2002 2 14
18. E.W. Ades, F.J. Candal, R.A. Swerlick, V.G. George, S. Summers, D.C. Bosse, and T.J. Lawley HMEC-1: establishment of an immortalized human microvascular endothelial cell line J. Invest. Dermatol. 99 1992 683 690
19. R.E. Unger, V. Krump-Konvalinkova, K. Peters, and C.J. Kirkpatrick In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R Microvasc. Res. 64 2002 384 397
20. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, and M.R. Boyd New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl. Cancer Inst. 82 1990 1107 1112
21. A. Krishan Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodine staining J. Cell Biol. 66 1975 188 193
22. J. Gong, F. Traganos, and Z. Darzynkiewicz A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry Anal. Biochem. 218 1994 314 319
23. D. Thaloor, A.K. Singh, G.S. Sidhu, P.V. Prasad, H.K. Kleinman, and R.K. Maheshwari Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin Cell Growth Differ. 9 1998 305 312
24. A.K. Joe, H. Liu, M. Suzui, M.E. Vural, D. Xiao, and I.B. Weinstein Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines Clin. Cancer Res. 8 2002 893 903
25. W.F. Tan, L.P. Lin, M.H. Li, Y.X. Zhang, Y.G. Tong, D. Xiao, and J. Ding Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential Eur. J. Pharmacol. 459 2003 255 262
26. K. Igura, T. Ohta, Y. Kuroda, and K. Kaji Resveratrol and quercetin inhibit angiogenesis in vitro Cancer Lett. 171 2001 11 16
27. R.P. Singh, and R. Agarwal Tumor angiogenesis: a potential target in cancer control by phytochemicals Curr. Cancer Drug Targets 3 2003 205 217
28. Y. Cao, R. Cao, and E. Brakenhielm Antiangiogenic mechanisms of diet-derived polyphenols J. Nutr. Biochem. 13 2002 380 390
29. J.L. Arbiser, N. Klauber, R. Rohan, R. van Leeuwen, M.T. Huang, C. Fisher, E. Flynn, and H.R. Byers Curcumin is an in vivo inhibitor of angiogenesis Mol. Med. 4 1998 376 383
30. B. Heissig, K. Hattori, M. Friedrich, S. Rafii, and Z. Werb Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases Curr. Opin. Hematol. 10 2003 136 141
31. A.K. Singh, P. Seth, P. Anthony, M.M. Husain, S. Madhavan, H. Mukhtar, and R.K. Maheshwari Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells Arch. Biochem. Biophys. 401 2002 29 37
32. T. Kondo, T. Ohta, K. Igura, Y. Hara, and K. Kaji Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding Cancer Lett. 180 2002 139 144
33. N. Oku, M. Matsukawa, S. Yamakawa, T. Asai, S. Yahara, F. Hashimoto, and T. Akizawa Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP Biol. Pharm. Bull. 26 2003 1235 1238
34. O.I. Aruoma, B. Halliwell, R. Aeschbach, and J. Loligers Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid Xenobiotica 22 1992 257 268
35. N. Maulik Redox signaling of angiogenesis Antioxid. Redox Signal. 4 2002 805 815
36. M.H. Kim Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases J. Cell. Biochem. 89 2003 529 538
37. N.H. Nam, Y. Kim, Y.J. You, D.H. Hong, H.M. Kim, and B.Z. Ahn Cytotoxic 2′,5′-dihydroxychalcones with unexpected antiangiogenic activity Eur. J. Med. Chem. 38 2003 179 187
38. B. Madan, S. Batra, and B. Ghosh 2′-Hydroxychalcone inhibits nuclear factor-kappaB and blocks tumor necrosis factor-alpha- and lipopolysaccharide-induced adhesion of neutrophils to human umbilical vein endothelial cells Mol. Pharmacol. 58 2000 526 534
39. G.M. Tozer, C. Kanthou, C.S. Parkins, and S.A. Hill The biology of the combretastatins as tumor vascular targeting agents Int. J. Exp. Pathol. 83 2002 21 38
40. J.P. Stevenson, M. Rosen, W. Sun, M. Gallagher, D.G. Haller, D. Vaughn, B. Giantonio, R. Zimmer, W.P. Petros, M. Stratford, D. Chaplin, S.L. Young, M. Schnall, and P.J. O'Dwyer Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow J. Clin. Oncol. 21 2003 4428 4438
41. C.M. West, and P. Price Combretastatin A4 phosphate Anticancer Drugs 15 2004 179 187
42. J. Folkman, and R. Kalluri Cancer without disease Nature 427 2004 787